71 – 80 of 341
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer : 8-Year Follow-up
(
- Contribution to journal › Article
-
Mark
Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume
(
- Contribution to journal › Article
-
Mark
Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer : Data from the Prostate Cancer Registry
(
- Contribution to journal › Article
-
Mark
The Value of a New Diagnostic Test for Prostate Cancer : A Cost-Utility Analysis in Early Stage of Development
(
- Contribution to journal › Article
-
Mark
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer : Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
2021) In Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39(20). p.2294-2303(
- Contribution to journal › Article
- 2020
-
Mark
Hospital readmissions after limited vs. extended lymph node dissection during open and robot-assisted radical prostatectomy
(
- Contribution to journal › Article
-
Mark
Intake of individual fatty acids and risk of prostate cancer in the European prospective investigation into cancer and nutrition
(
- Contribution to journal › Article
-
Mark
Associations between intraoperative factors and surgeons’ self-assessed operative satisfaction
(
- Contribution to journal › Article
-
Mark
Treatment of High-grade Non–muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations : Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial “NIMBUS”
(
- Contribution to journal › Article
-
Mark
Introducing PIONEER : a project to harness big data in prostate cancer research
(
- Contribution to journal › Article